Loading organizations...
Key people at Morgan Noble Healthcare Partners.
Morgan Noble Healthcare Partners was founded in 1997 by Robert Haft (Managing Partner & Founder).
Morgan Noble Healthcare Partners is a principal investment firm, deploying its own capital into healthcare services and information technology sectors. The firm targets both majority and minority investment opportunities, focusing on companies with promising models and technologies. This strategic approach supports ventures poised to make significant contributions to the evolving healthcare landscape.
Established in 1997, the firm was founded by Robert Haft, who continues as Managing Partner. Haft’s entrepreneurial background informs Morgan Noble’s investment philosophy. Its inception was driven by insight into the healthcare market’s growth opportunities, recognizing the critical need for dedicated capital and expertise to scale innovative health solutions.
Morgan Noble Healthcare Partners serves as a key financial and strategic partner for growth-oriented healthcare companies. By providing capital and guidance, the firm catalyzes advancements that enhance healthcare delivery and operational efficiency. Its vision is to cultivate a portfolio of successful healthcare enterprises, contributing to improved patient outcomes and industry innovation.
Key people at Morgan Noble Healthcare Partners.
Morgan Noble Healthcare Partners was founded in 1997 by Robert Haft (Managing Partner & Founder).
Morgan Noble Healthcare Partners has 4 tracked investments across 3 companies. The latest tracked deal is $53.0M Series C in Finch Therapeutics in August 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 22, 2019 | Finch Therapeutics | $53.0M Series C | — | Avenir, OCV Partners, Shumway Capital, Susquehanna International Group, SymBiosis, Trans Pacific Technology Fund, Willett Advisors |
| Mar 1, 2018 | Finch Therapeutics | $36.0M Series B | — | Avenir, Chris Shumway, Willett Advisors |
| Sep 1, 2017 | Intabio | $2.0M Seed | — | Cultivation Capital, Genoa Ventures, Michael Finney, William (Bill) Hyun, Vertical Ventures |
| Sep 16, 2014 | Privia Health | $400.0M Other Equity | Thomas Carella | Brighton Health Partners, Cardinal Partners, Health Enterprise Partners, Pamplona Capital Management |